Literature DB >> 12538764

A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment.

James G Wakefield1, David J Stephens, Jeremy M Tavaré.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is a conserved, multifunctional kinase that is constitutively active in resting cells, and inactivated through phosphorylation by protein kinase B (PKB). We have investigated the temporal and spatial control of GSK-3 phosphorylation during the cell cycle in mammalian cells. We show that GSK-3 is present along the length of spindle microtubules and that a fraction of GSK-3 is phosphorylated during mitosis. Phospho-GSK-3 is abundant at the centrosomes and spindle poles but absent from other areas of the spindle. GSK-3 phosphorylation occurs concomitantly with the appearance of phosphorylated and active PKB at the centrosome, which suggests that PKB is the kinase responsible for phosphorylating and inactivating GSK-3 at the centrosome during mitosis. We demonstrate that lithium and two structurally distinct inhibitors of GSK-3 promote defects in microtubule length and chromosomal alignment during prometaphase. Treated cells contain mono-oriented chromosomes concentrated at the plus ends of astral microtubules, which are longer than in untreated cells. Live microscopy of cells expressing Histone-2B-GFP confirms that the inhibition of GSK-3 suppresses mitotic chromosome movement and leads to a prometaphase-like arrest. We propose that GSK-3 is regulated in a temporal and spatial manner during mitosis and, through controlling microtubule dynamics, plays an important role in chromosomal alignment on the metaphase plate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538764     DOI: 10.1242/jcs.00273

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  70 in total

1.  Identification of S6K2 as a centrosome-located kinase.

Authors:  Rossella Rossi; John M Pester; Mitch McDowell; Samuela Soza; Alessandra Montecucco; Kay K Lee-Fruman
Journal:  FEBS Lett       Date:  2007-07-30       Impact factor: 4.124

Review 2.  The canonical Wnt signalling pathway and its APC partner in colon cancer development.

Authors:  Jean Schneikert; Jürgen Behrens
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  Chemical genetics: reshaping biology through chemistry.

Authors:  Stefan Florian; Stefan Hümmer; Mario Catarinella; Thomas U Mayer
Journal:  HFSP J       Date:  2007-07-12

Review 5.  Mitotic and mitogenic Wnt signalling.

Authors:  Christof Niehrs; Sergio P Acebron
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

6.  EFHC1 interacts with microtubules to regulate cell division and cortical development.

Authors:  Laurence de Nijs; Christine Léon; Laurent Nguyen; Joseph J Loturco; Antonio V Delgado-Escueta; Thierry Grisar; Bernard Lakaye
Journal:  Nat Neurosci       Date:  2009-09-06       Impact factor: 24.884

7.  Centrosomal localization of Diversin and its relevance to Wnt signaling.

Authors:  Keiji Itoh; Andreas Jenny; Marek Mlodzik; Sergei Y Sokol
Journal:  J Cell Sci       Date:  2009-09-29       Impact factor: 5.285

8.  Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer.

Authors:  Michel V Hadjihannas; Martina Brückner; Boris Jerchow; Walter Birchmeier; Wolfgang Dietmaier; Jürgen Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

9.  Differentially expressed micoRNAs in human oocytes.

Authors:  Yan-Wen Xu; Bin Wang; Chen-Hui Ding; Tao Li; Fang Gu; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2011-06-07       Impact factor: 3.412

10.  Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors.

Authors:  Andrew J Olaharski; Nina Gonzaludo; Hans Bitter; David Goldstein; Stephan Kirchner; Hirdesh Uppal; Kyle Kolaja
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.